CTEV — Claritev Corporation
NYSE
Q3 2025 Earnings Call Summary
November 7, 2025
CTEV Q3 2025 Earnings Call Summary
1. Key Financial Results and Metrics
- Total Revenue: $246 million, up 6.7% year-over-year.
- Adjusted EBITDA: $155.1 million, reflecting a growth of 9.5%, with EBITDA margins at 63.1%.
- Year-to-Date Performance: Revenue up nearly 3% and adjusted EBITDA up 3.7%, marking the best revenue performance in 12 quarters.
- Annual Contract Value (ACV): Closed $15 million in ACV during Q3, with a year-to-date total of approximately $60 million expected by year-end.
- Cash Flow: Levered free cash flow was a use of $16.3 million, while unlevered free cash flow was $113 million, achieving a 73% cash conversion rate.
2. Strategic Updates and Business Highlights
- Transformation Strategy: The company has successfully executed its transformation plan ahead of schedule, focusing on client relationships and operational efficiency.
- Market Vertical Expansion: Claritev has established six focused market verticals, with significant growth in payer and TPA relationships, and a successful entry into international markets, particularly the Middle East.
- Client Renewals: Renewed contracts with all top 10 clients, providing stability and predictability for future growth.
- Product Development: Continued investment in technology, AI, and analytics to enhance service offerings, particularly in payment integrity and transparency solutions.
3. Forward Guidance and Outlook
- Revenue Guidance: Raised full-year revenue growth expectations to approximately 2.8% to 3.2%.
- Adjusted EBITDA Margin Guidance: Tightened to a range of 62.5% to 63%.
- 2026 Outlook: Anticipated mid-single-digit revenue growth, with expectations for 60% to 65% of new ACV to convert to revenue next year.
4. Bad News, Challenges, or Points of Concern
- Regulatory Environment: Uncertainty surrounding government regulations and potential impacts from the HR.1 implementation.
- Competitive Pressures: Increased competition in the NSA market, with providers winning a significant majority of disputes, which could affect future revenue from this segment.
- Investment Costs: Higher personnel costs due to transformation-related investments, which may pressure margins in the short term.
5. Notable Q&A Insights
- Guidance Clarification: Management indicated that while revenue growth is expected to be stable, there are fixed costs that could temper EBITDA margins due to ongoing investments.
- ACV Conversion: The $60 million in new ACV is expected to be incremental to core business growth, with a significant portion converting to revenue in 2026.
- NSA Business Dynamics: The company has seen operational improvements in its NSA product, but the competitive landscape remains challenging, with providers winning 80% of disputes.
Overall, Claritev Corporation demonstrated strong financial performance in Q3 2025, with a clear strategic focus on growth and client retention, despite facing challenges in the regulatory environment and competitive pressures. The company is optimistic about its future trajectory as it prepares for 2026.
